Clinical Trial Update: An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney Function [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety study of bortezomib in patients with multiple myeloma and limited kidney function; the trial was terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2013-08-28